Choosing the Most Suitable Particle Sample Point Locations
Considerations for particle counter isokinetic probe placement to ensure effective cleanroom monitoring
The Particle Measuring Systems (PMS) environmental system designers are often asked how to choose clean room sampling points, whether it be performed in a pharmaceutical cleanroom or clean device (RABS, isolator, etc.).
The answer is not always straightforward. There are several guidance documents that offer advice on what processes need to be monitored, along with advice on suitable distances from the process being monitored. The goal of this article is to identify the considerations, establish the most suitable location for monitoring a process, and build a scientific rationale for that decision.
Particle counting in pharmaceutical applications can be clearly segregated into one of three categories: certification, qualification and monitoring. Each category requires a different approach.
Certification is measuring a cleanroom for a standard. The standard recognized worldwide is ISO14644-1, “Classification of air cleanliness by particle concentration”, which defines how a cleanroom performs and its ability to show uniformity across the entire space. This is done irrespective of the activities performed in it.
Qualification is the process of analyzing risk assessment for the activities in the room. Qualification follows grid methodology testing methods. Particle counts are measured in both operational and at-rest states; however, the operational data is the most valid.
Monitoring is the ongoing sampling of the cleanroom on a frequency relative to the degree of control required to prove management over risk to the finished product. The number of sample points and their location is determined by risk assessment, and the qualification and certification process.
As mentioned above, cleanroom certification is based on ISO14644-1, “Classification of air cleanliness by particle concentration” standards. The specifics of the assessment may vary slightly for FDA or EU GMP regulations, but the underlying methodology is standard.
Certification demonstrates that the entire area meets a specific ISO classification by particle concentration. That is, irrespective of the final use of the room, the design and implementation of the filtration system are considered. The international standard means that a cleanroom tested to meet compliance for ISO 5 standards will meet that standard independent of geography and regulatory aspects (i.e.: FDA or EU GMP). This provides a universal standard to show that a cleanroom level has been established.
There are many different resources to prove ISO compliance and this paper will not cover these in depth. However, using the example of a classic filling machine (Grade A/ISO5) within a Grade B (ISO7) background area, the basic rules of testing can be demonstrated.
Please help us understand your needs and download the complete paper by completing the form on the right.
Particle Measuring Systems’ cleanroom viable non viable cleanoom monitoring instruments, include:
Active Air Samplers
- MiniCapt mobile active air sampler
- MiniCapt Remote microbial air sampler
- BioCapt Single Use microbial impactors
- IsoAir Pro-Plus Remote Particle Counter (with built-in pump)
- Airnet® II Particle Sensor
- Lasair Pro Portable Particle Counter
- DataAnalyst interactive software can even step the user through the certification process.
- HandiLaz Mini II handheld particle counter
Complete and customizable turn-key facility monitoring
Ongoing Monitoring – Choosing the Most Suitable Particle Sample Point Locations in the Cleanroom
Qualification – Choosing the Most Suitable Particle Sample Point Locations in the Cleanroom
Certification – Choosing the Most Suitable Particle Sample Point Locations in the Cleanroom
Choosing the Most Suitable Particle Sample Point Locations in the Cleanroom
Particle Monitoring in Powder Filling: Sample Points and Risk Analysis
Choosing the Right Complete Contamination Control Solutions Provider
Microbiological Plate Incubation and Pharmaceutical Risk Assessment